We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Avacta Life Sciences Takes on the $55BN Antibody Market with Launch of Affimers

News   Sep 30, 2014

 
Avacta Life Sciences Takes on the $55BN Antibody Market with Launch of Affimers
 
 
 

RELATED ARTICLES

T Cells Attack and Kill Dopamine-Producing Cells in Parkinson's disease

News

Researchers in Germany discover a potential new target for treating Parkinson's disease

READ MORE

Working Together Helps Phage Overcome CRISPR

News

Surprising results show that phage join forces to overcome bacteria’s CRISPR -based immune defenses. Improved understanding of the interactions between phage and their bacterial hosts could help advance phage-based therapies and stimulate viral research.

READ MORE

CRISPR Screening Reveals Sickle Cell Disease Target

News

A key signaling protein, known as heme-regulated inhibitor (HRI), has been identified as a potential therapeutic target for the development of drugs to treat sickle cell disease, using a CRISPR screening approach.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE